Estrogen receptor dimerization: Ligand binding regulates dimer affinity and dimer dissociation rate

Molecular Endocrinology

Volumn 16, Issue 12, 2002, Pages 2706-2719

  Tamrazi, Anobel ^a   Carlson, Kathryn E ^a   Daniels, Jonathan R ^a   Hurth, Kyle M ^a   Katzenellenbogen, John A ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,1,1 TRICHLORO 2 (2 CHLOROPHENYL) 2 (4 CHLOROPHENYL)ETHANE; 11BETA CHLOROMETHYLESTRADIOL; 11BETA ETHYL 17ALPHA ETHYNYLESTRIOL; 11BETA ETHYLESTRIOL; ANTIESTROGEN; BENZESTROL; BETA ZEARALENOL; CELL NUCLEUS RECEPTOR; CYCLOFENIL; CYSTEINE; DIETHYLSTILBESTROL; DIMER; ESTRADIOL; ESTRIOL; ESTROGEN RECEPTOR ALPHA; ESTRONE; FULVESTRANT; FURAN DERIVATIVE; GENISTEIN; HEXESTROL; HYDROXYTAMOXIFEN; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; P 1498; PYRAZOLE DERIVATIVE; RALOXIFENE; TAMOXIFEN; TETRAHYDROCHRYSENE DERIVATIVE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ZERANOL;

ARTICLE; DIMERIZATION; DISSOCIATION; FLUORESCENCE; FLUORESCENCE RESONANCE ENERGY TRANSFER; KINETICS; LIGAND BINDING; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN STABILITY; THERMODYNAMICS;

BINDING SITES; CYSTEINE; DIMERIZATION; DRUG STABILITY; ENERGY TRANSFER; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FLUORESCENT DYES; HISTONE ACETYLTRANSFERASES; HUMANS; KINETICS; LIGANDS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; MUTAGENESIS, SITE-DIRECTED; PROTEIN BINDING; RECEPTORS, ESTROGEN; SPECTROMETRY, FLUORESCENCE; STRUCTURE-ACTIVITY RELATIONSHIP; THERMODYNAMICS; TRANSCRIPTION FACTORS; TRITIUM;

EID: 0036908594     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2002-0250     Document Type: Article

References (44)

1. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P 1995 The nuclear receptor superfamily: The second decade. Cell 83:835-839
2. Olefsky JM 2001 Nuclear receptor minireview series. J Biol Chem 276:36863-36864
3. Lees JA, Fawell SE, White R, Parker MG 1990 A 22-amino-acid peptide restores DNA-binding activity to dimerization-defective mutants of the estrogen receptor. Mol Cell Biol 10:5529-5531
4. Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engström O, Öhman L, Greene GL, Gustafsson J-A, Carlquist M 1997 Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389:753-758
5. Schwabe JWR, Chapman L, Finch JT, Rhodes D 1993 The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: How receptors discriminate between their response elements. Cell 75:567-578
6. Salomonsson M, Häggblad J, O'Malley BW, Sitbon GM 1994 The human estrogen receptor hormone binding domain dimerizes independently of ligand activation. J Steroid Biochem Mol Biol 48:447-452
7. Brandt ME, Vickery LE 1997 Cooperativity and dimerization of recombinant human estrogen receptor hormone-binding domain. J Biol Chem 272:4843-4849
8. Tanenbaum DM, Wang Y, Williams SP, Sigler PB 1998 Crystallographic comparison of the estrogen and progesterone receptors ligand binding domains. Proc Natl Acad Sci USA 95:5998-6003
9. Wang H, Peters GA, Zeng X, Tang M, Ip W, Khan SA 1995 Yeast two-hybrid system demonstrates that estrogen receptor dimerization is ligand-dependent in vivo. J Biol Chem 270:23322-23329
10. Erijman L, Weber G 1993 Use of sensitized fluorescence for the study of the exchange of subunits in protein aggregates. Photochem Photobiol 57:411-415
11. Waggoner A 1995 Covalent labeling of proteins and nucleic acids with fluorophores. Methods Enzymol 246:362-373
12. Hegy GB, Shackleton CHL, Carlquist M, Bonn T, Engstrom O, Sjoholm P, Witkowska HE 1996 Carboxymethylation of the human estrogen receptor ligand-binding domain-estradiol complex: HPLC/ESMS peptide mapping shows that cysteine 447 does not react with iodoacetic acid. Steroids 61:367-373
13. Goldstein SW, Bordner J, Hoth LR, Geoghegan KF 2001 Chemical and biochemical issues related to X-ray crystallography of the ligand-binding domain of estrogen receptor α. Bioconjug Chem 12:406-413
14. Reese JC, Katzenellenbogen BS 1992 Characterization of a temperature-sensitive mutation in the hormone binding domain of the human estrogen receptor: Studies in cell extracts and intact cells and their implications for hormone-dependent transcriptional activation. J Biol Chem 267:9868-9873
15. Stoica A, Pentecost E, Martin MB 2000 Effects of selenite on estrogen receptor α expression and activity in MCF-7 breast cancer cells. J Cell Biochem 79:282-292
16. Neff S, Sadowski C, Miksicek R 1994 Mutational analysis of cysteine residues within the hormone-binding domain of the human estrogen receptor identifies mutants that are defective in both DNA-binding and subcellular distribution. Mol Endocrinol 8:1215-1223
17. Reese JC, Katzenellenbogen BS 1991 Mutagenesis of cysteines in the hormone binding domain of the human estrogen receptor: Alterations in binding and transcriptional activation by covalently and reversibly attaching ligands. J Biol Chem 266:10880-10887
18. Gangloff M, Ruff M, Eiler S, Duclaud S, Wurtz JM, Moras D 2001 Crystal structure of a mutant hERα ligand-binding domain reveals key structural features for the mechanism of partial agonism. J Biol Chem 276:15059-15065
19. Reese JC, Wooge CH, Katzenellenbogen BS 1992 Identification of two cysteines closely positioned in the ligand binding pocket of the human estrogen receptor: Roles in ligand binding and transcriptional activation. Mol Endocrinol 6:2160-2166
20. Seielstad DA, Carlson KE, Kushner PJ, Greene GL, Katzenellenbogen JA 1995 Analysis of the structural core of the human estrogen receptor ligand binding domain by selective proteolysis/mass spectrometric analysis. Biochemistry 34:12605-12615
21. Seielstad DA, Carlson KE, Katzenellenbogen JA, Kushner PJ, Greene GL 1995 Molecular characterization by mass spectrometry of the human estrogen receptor ligand-binding domain expressed in Escherichia coli. Mol Endocrinol 9:647-658
22. Selvin PR 1995 Fluorescence resonance energy transfer. Methods Enzymol 246:300-334
23. Stauffer SR, Huang YR, Aron ZD, Colleta CJ, Sun J, Katzenellenbogen BS, Katzenellenbogen JA 2001 Triarylpyrazoles with basic side chains: Development of pyrazole-based estrogen receptor antagonists. Bioorg Med Chem 9:151-161
24. Mortensen DS, Rodriguez AL, Carlson KE, Sun J, Katzenellenbogen BS, Katzenellenbogen JA 2001 Synthesis and biological evaluation of a novel series of furans: Ligands selective for estrogen receptor α. J Med Chem 44:3838-3848
25. Mortensen DS, Rodriguez AL, Sun J, Katzenellenbogen BS, Katzenellenbogen JA 2001 Furans with basic side chains: Synthesis and biological evaluation of a novel series of antagonists with selectivity for the estrogen receptor α. Bioorg Med Chem Lett 11:2521-2524
26. 3H]estradiol-17β: A very high affinity, reversible ligand for the estrogen receptor. J Steroid Biochem 28:361-370
27. Kraichely DM, Sun J, Katzenellenbogen JA, Katzenellenbogen BS 2000 Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-α and estrogen receptor-β: Correlations with biological character and distinct differences among SRC coactivator family members. Endocrinology 141:3534-3545
28. Meyers MJ, Sun J, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA 1999 Estrogen receptor subtype-selective ligands: Asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl-5,6,11,12-tetrahydrochrysenes. J Med Chem 42:2456-2468
29. Carlson KE, Choi I, Gee A, Katzenellenbogen BS, Katzenellenbogen JA 1997 Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: Evidence that an open pocket conformation is required for ligand interaction. Biochemistry 36:14897-14905
30. Gee AC, Carlson KE, Martini PGV, Katzenellenbogen BS, Katzenellenbogen JA 1999 Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor. Mol Endocrinol 13:1912-1923
31. Yudt MR, Koide S 2001 Preventing estrogen receptor action with dimer-interface peptides. Steroids 66:549-558
32. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, Greene GL 1998 The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95:927-937
33. Sack JS, Kish KF, Wang C, Attar RM, Kiefer SE, An Y, Wu GY, Scheffler JE, Salvati ME, Krystek SR, Weinmann R, Einspahr H 2001 Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone. Proc Natl Acad Sci USA 98:4904-4909
34. Peters GA, Khan SA 1999 Estrogen receptor domains E and F: Role in dimerization and interaction with coactivator RIP-140. Mol Endocrinol 13:286-296
35. Dauvois S, Danielian PS, White R, Parker MG 1992 Antiestrogen ICI164,384 reduces cellular estrogen receptor content by increasing its turnover. Proc Natl Acad Sci USA 89:4037-4041
36. Pike ACW, Brzozowski AM, Walton J, Hubbard RE, Thorsell A, Gustafsson JA, Carlquist M 2001 Structural insights into the mode of action of a pure antiestrogen. Structure 9:145-153
37. Bramlett KS, Yifei W, Burris TP 2001 Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes. Mol Endocrinol 15:909-922
38. Margeat E, Poujol N, Boulahtouf A, Chen Y, Muller JD, Gratton E, Cavailles V, Royer C 2001 The human estrogen receptor α dimer binds a single SRC-1 coactivator molecule with an affinity dictated by agonist structure. J Mol Biol 306:433-442
39. Nolte RT, Wisely GB, Westin S, Cobb JE, Lambert MH, Kurokawa R, Rosenfeld MG, Willson TM, Glass CK, Milburn MV 1998 Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ. Nature 395:137-143
40. Napolitano E, Fiaschi R, Carlson KE, Katzenellenbogen JA 1995 11β-Substituted estradiol derivatives 2: Potential carbon-11 and iodine-labeled probes for the estrogen receptor. J Med Chem 38:2774-2779
41. Katzenellenbogen JA, Johnson Jr HJ, Myers HN 1973 Photoaffinity labels for estrogen binding proteins of rat uterus. Biochemistry 12:4085-4092
42. Scatchard G 1949 The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51:660-672
43. Tetin SY, Hazlett TL 2000 Optical spectroscopy in studies of antibody-hapten interactions. Methods 20:341-361
44. Tetin SY, Rumbley CA, Hazlett TL, Voss EW 1993 Elucidation of anti-ssDNA autoantibody BV 04-01 binding interactions with homooligonucleotides. Biochemistry 32:9011-9017